Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesOphthalmology/OptometryGold Coast Health Plan Ozurdex Coverage | OpenPaye…
    Ask Trek AI about this page
    CurrentGold Coast Health PlanPolicy N/A

    Ozurdex (dexamethasone, intravitreal implant) Coverage Criteria

    Customize your policy alerts

    Sign up for all goldcoasthealthplan policy alerts

    Know when goldcoasthealthplan releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs prior authorization and Part B coverage for Ozurdex for specified retinal and ocular inflammatory conditions under Gold Coast Health Plan Medicare Advantage.

    Policy Summary
    PayerGold Coast Health Plan
    PolicyOzurdex (dexamethasone, intravitreal implant) Coverage Criteria
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateAug 21, 2025
    Last ReviewAug 21, 2025
    Next Review DateN/A
    Key ActionSubmit medical records supporting the prior authorization request and confirm that the requested use matches a covered Ozurdex indication.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    3Covered clinical uses
    J7312Covered HCPCS code
    0.1 mgBilling unit
    0.7 mgImplant strength
    Required

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Supporting records

    Covered Uses and Documentation Requirements

    Covered Uses

    Ozurdex is indicated for any of the following covered uses:

    Covered indications

    • Macular edema following BRVO or CRVO: Treatment of macular edema following branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO).
    • Non-infectious posterior uveitis: Treatment of non-infectious uveitis affecting the posterior segment of the eye.
    • Diabetic macular edema: Treatment of diabetic macular edema in patients who are pseudophakic or are phakic and scheduled for cataract surgery.Patient must be pseudophakic or phakic and scheduled for cataract surgery
    title
    Covered Uses

    Required Medical Information

    The following requirement applies to each request:

    Required medical information: Medical records supporting the request must be provided.

    Covered Billing Information

    Covered HCPCS CodeHCPCSCovered
    J7312Ozurdex (dexamethasone, intravitreal implant) Billing unit: 0.1 mg
    J7312 Billing Unit
    Billing unit0.1 mg
    Ozurdex Implant Supplied
    Implant supplied0.7 mg implant

    Prior Authorization Submission Requirements

    Prior Authorization

    Medical records required

    Prior authorization requests must include medical records supporting the request. Coverage is limited to the specified Ozurdex indications.

    Documentation Required

    Submit supporting medical records

    Medical records supporting the request must be provided with each request for Ozurdex coverage.

    Denial Risk

    Unsupported indication or missing records

    Therapy Overview

    Ozurdex is a dexamethasone intravitreal implant used to reduce ocular inflammation and retinal vascular leakage. This policy addresses prior authorization and Part B coverage for specified conditions, including macular edema following branch or central retinal vein occlusion, non-infectious posterior uveitis, and diabetic macular edema in patients who are pseudophakic or phakic and scheduled for cataract surgery.

    Policy Summary
    PayerGold Coast Health Plan
    PolicyOzurdex (dexamethasone, intravitreal implant) Coverage Criteria
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateAug 21, 2025
    Last ReviewAug 21, 2025
    Next Review DateN/A
    Key ActionSubmit medical records supporting the prior authorization request and confirm that the requested use matches a covered Ozurdex indication.
    SourceLink
    On This Page
    Covered Uses and Documentation RequirementsCovered Billing InformationPrior Authorization Submission RequirementsTherapy Overview

    Coverage may be denied when the request is not supported by medical records or the requested use does not match one of the covered indications for Ozurdex.